Jing Yang

7PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 31, 2026
Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs.

Mingqi Hou, Wenjun Zhang, Ziping Qi

|Dec 03, 2025
Targeting DESI2 as a Novel Therapeutic Strategy for JAK2-Mutant Leukemias.

Husheng Mei, Wuqiang Wen, Wenjun Zhang

|Aug 06, 2024
Time - The fourth dimension of immune cells.

Guiming Li, Wenjun Zhang, Jing Yang

|May 16, 2023
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2.

Yiying Xue, Husheng Mei, Yisa Chen

|Feb 22, 2023
Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19.

Yisa Chen, Yiying Xue, Jing Yang

|Jan 17, 2022
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.

Jing Yang, Ellen L Weisberg, Shuang Qi

Pageof 2

Frequent Collaborators

2 joint publications

Ellen L Weisberg

2 joint publications

James D Griffin

2 joint publications

Sara J Buhrlage

2 joint publications

Jing Liu